H

HarmonIQ Biosciences

“Empowering health through continuous hormone monitoring.”

HealthtechPre-SeedRaising $2.0M

Open round — HarmonIQ Biosciences is raising $2.0M for its Pre-Seed

The founder is taking investor conversations now, and on PitchSpark you reach them directly — no warm intro, no gatekeeper.

02

Overview

Founded by Mario Sierra, CCRC, HarmonIQ Biosciences aims to redefine personal health understanding by making continuous hormone insights accessible to everyone. Their mission is to empower individuals to take control of their health through real-time, science-driven data.

03

Traction

as reported by the founder

HarmonIQ Biosciences completed a seed funding round on May 2, 2025, indicating strong investor confidence in their innovative approach.

What problem are you solving?

The company addresses the lack of accessible, real-time hormone data, enabling individuals to monitor hormonal changes continuously and make informed health decisions.

What is your moat?

HarmonIQ's competitive advantage lies in its unique aptamer-based sensing platform integrated into wearable technology, offering precise and continuous hormone monitoring previously confined to laboratory settings.

What is your market size?

The wearable health technology market is rapidly expanding, with increasing consumer demand for personalized health monitoring solutions.

Who are your competitors?

Main competitors include BioSens8 and Personalized Lifestyle Medicine Institute. HarmonIQ differentiates itself through its innovative wearable device and real-time hormone data delivery.

10

Company updates

No updates posted yet.

Follow this company

Get an email when HarmonIQ Biosciences posts an update. No account needed — one click to unsubscribe.

HarmonIQ Biosciences — raising $2.0M